Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: A randomized, controlled clinical trial

Pediatric Infectious Disease Journal

Volumn 23, Issue 8, 2004, Pages 719-725

  Darmstadt, Gary L ^a,b   Badrawi, Nadia ^c   Law, Paul A ^a   Ahmed, Saifuddin ^a   Bashir, Moataza ^c   Iskander, Iman ^c   Al Said, Dalia ^c   El Kholy, Amani ^c   Husein, Mohamed Hassan ^c   Alam, Asif ^d   Winch, Peter J ^a   Gipson, Reginald ^e   Santosham, Muhammad ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SAVE THE CHILDREN   (United States)

^c CAIRO UNIVERSITY   (Egypt)

^d DHAKA SHISHU HOSPITAL   (Bangladesh)

^e JOHN SNOW INC   (United States)

Author keywords

Developing country; Invasive bacterial infections; Neonate; Nosocomial infection; Preterm infants; Prevention; Skin barrier; Sunflower seed oil (topical); Topical therapy

Indexed keywords

SUNFLOWER OIL;

ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DEVELOPING COUNTRY; DRUG INDICATION; EGYPT; EPIDEMIOLOGICAL DATA; FEMALE; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN PROTECTION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; BACTERIAL INFECTIONS; CROSS INFECTION; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; HELIANTHUS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; MALE; PHARMACEUTIC AIDS; PLANT OILS;

EID: 4043108371     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000133047.50836.6f     Document Type: Article

References (52)

1. World Health Organization. Perinatal mortality: a listing of available information. In: Maternal Health and Safe Motherhood Programme. Geneva, Switzerland: WHO; 1996.
2. Save the Children Federation. State of the World's Newborns. 2001:1-48.
3. Marsh DR, Darmstadt GL, Moore J, Daly P, Oot D, Tinker A. Advancing newborn health and survival in developing countries: a conceptual framework. J Perinatol. 2002;22:572-576.
4. Darmstadt GL, Black RE, Santosham M. Research priorities and postpartum-care strategies for the prevention and treatment of neonatal infections in less developed countries. Pediatr Infect Dis J. 2000;19:739-750.
5. Moss W, Darmstadt GL, Marsh DR, Black RE, Santosham M. Research priorities for the reduction of perinatal and neonatal morbidity and mortality in developing country communities. J Perinatol. 2002;22:484-495.
6. Darmstadt GL, Costello A, Lawn J. Advancing the state of the world's newborns. Bull World Health Organ. 2003;81:224-225.
7. Bang AT, Bang RA, Baitule SB, Reddy MH, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet. 1999;354:1955-1961.
8. World Health Organization. Mother-baby package: implementing safe motherhood in countries. In: Maternal Health and Safe Motherhood Programme. Geneva, Switzerland: WHO; 1994.
9. Yoshio H, Tollin M, Gudmundsson GH, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res. 2003;53:211-216.
10. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am. 2000;47:757-782.
11. Darmstadt GL. The skin and nutritional disorders of the newborn. Eur J Pediatr Dermatol. 1998;8:221-228.
12. Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 1997;24:1-21.
13. Darmstadt GL, Saha SK, Ahmed ASMNU, Khatun M, Chowdhury MAKA. The skin as a potential portal of entry for invasive infections in neonates. Perinatology. 2003;5:205-212.
14. Prottey C, Hartop PJ, Black JG, McCormack JI. The repair of impaired epidermal barrier function in rats by the cutaneous application of linoleic acid. Br J Dermatol. 1976;94:13-21.
15. Prottey C. Investigation of functions of essential fatty acids in the skin. Br J Dermatol. 1977;97:29-38.
16. Prottey C. Essential fatty acids and the skin. Br J Dermatol. 1976;94:579-587.
17. Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol. 1980;74:230-233.
18. Hartop PJ, Prottey C. Changes in transepidermal water loss and the composition of epidermal lecithin after applications of pure fatty acid triglycerides to the skin of essential fatty acid-deficient rats. Br J Dermatol. 1976;95:255-64.
19. Houtsmuller UM, van der Beek A. Effects of topical application of fatty acids. Prog Lipid Res. 1981;20:219-24.
20. Darmstadt GL, Mao-Qiang M, Chi E, Saha SK, Ziboh VA, Black RE, Santosham M, Elias PM. Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr. 2002;91:1-9.
21. Friedman Z, Shochat SJ, Maisels MJ, Marks KH, Lamberth EL. Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil. Pediatrics. 1976;58:650-654.
22. Postuma R, Pease PW, Watts R, Taylor S, McEvoy FA. Essential fatty acid deficiency in infants receiving parenteral nutrition. J Pediatr Surg. 1978;13:393-398.
23. Press M, Hartop PJ, Prottey C. Correction of essential fatty acid deficiency in man by the cutaneous application of sunflower-seed oil. Lancet. 1974;1:597-599.
24. Prottey C, Hartop PJ, Press M. Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower seed oil to the skin. J Invest Dermatol. 1975;64:228-234.
25. Schurer N, Schliep V, Williams ML. Differential utilization of linoleic and arachidonic acid by cultured human keratinocytes. Skin Pharmacol. 1995;8:30-40.
26. Elias PM, Mao-Qiang M, Thornfeldt CR, Feingold KR. The epidermal permeability barrier: effects of physiologic and non-physiologic lipids. In: Hoppe U, ed. The Lanolin Book. Hamburg, Germany: Beiersdorf AG; 1999:253-279.
27. Nopper AJ, Horii KA, Sookdeo-Drost S, Wang TH, Mancini AJ, Lane AT. Topical ointment therapy benefits premature infants. J Pediatr. 1996;128:660-669.
28. Pabst RC, Starr KP, Qaiyumi S, Schwalbe RS, Gewolb IH. The effect of application of Aquaphor on skin condition, fluid requirements, and bacterial colonization in very low birth weight infants. J Perinatol. 1999;19:278-283.
29. Lane AT, Drost SS. Effects of repeated application of emollient cream to premature neonates' skin. Pediatrics. 1993;92:415-419.
30. Edwards WH, Conner JM, Soll RF. The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000 grams. Pediatrics. 2004;113:1194-1203.
31. Fernandez A, Patkar S, Chawla C, et al. Oil application in preterm babies, a source of warmth and nutrition. Indian Pediatr. 1987;24:1111-1117.
32. Johanson RB, Spencer SA, Rolfe P, et al. Effect of post-delivery care on neonatal body temperature. Acta Paediatr. 1992;81:859-863.
33. Agarwal KN, Gupta A, Pushkarna R, Bhargava SK, Faridi MM, Prabhu MK. Effect of massage and use of oil on growth, blood flow and sleep pattern in infants. Indian J Med Res. 2000;112:212-217.
34. Wallace M, Lindado S, Bedrick A, Moravec C, Nieto S. Decreasing bloodstream infection rates in very low birth weight infants with topical ointment therapy [abstract]. Infect Control Hosp Epidemiol. 1998;19:689.
35. Conner JM, Soll RF, Edwards WH. Topical ointment for preventing infection in preterm infants (Cochrane Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons; 2004:Issue 1.
36. Ballard JL, Khoury JC, Wedig K, Wang L, Ellers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417-423.
37. Dubowitz LMS, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970;77:1-10.
38. Greenland S. Introduction to regression modeling. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams Wilkins; 1998:401-432.
39. Darmstadt GL, Saha SK. Traditional practice of oil massage of neonates in Bangladesh. J Health Pop Nutr. 2002;20:175-179.
40. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study. Pediatrics. 2000;105:1041-1045.
41. Ramsey KM, Malone SG, Fey PD, et al. Aquaphor as a source of colonization and subsequent blood stream infections among very low birthweight neonates [abstract 53]. Infect Control Hosp Epidemiol. 1998;19:689.
42. Bhutta ZA. Neonatal bacterial infections in developing countries: strategies for prevention. Semin Neonatol. 1999;4:159-71.
43. WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J. 1999;18:S1-S22.
44. Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol. 1994;15:315-318.
45. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. JAMA. 1987;258:2396-2402.
46. Falkow S. Invasion and intracellular sorting of bacteria: searching for bacterial genes expressed during host/pathogen interactions. J Clin Invest. 1997;100:239-243.
47. Jonas M, Darmstadt GL, Rubens CE, Chi EY. Ultrastructure of invasion of group A Streptococcus into human keratinocytes. In: Proceedings of the 14th International Congress on Electron Microscopy. vol 4. 1998:375-376.
48. Darmstadt GL, Fleckman P, Jonas M, Chi E, Rubens CE. Differentiation of cultured keratinocytes promotes adherence of Streptococcus pyogenes. J Clin Invest. 1998;101:128-136.
49. Darmstadt GL, Mentele L, Podbielski A, Rubens CE. Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun. 2000;68:1215-1221.
50. Mao-Qiang M, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106:1096-1101.
51. Mao-Qiang M, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993;129:728-738.
52. Hanley K, Jiang Y, Crumrine D, et al. Activators of the nuclear hormone receptors PPARa and FXR accelerate the development of the fetal epidermal permeability permeability barrier. J Clin Invest. 1997;100:705-712.